The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Inflammatory responses in Ebola virus-infected patients
Open accessAbstract
SUMMARY: Ebola virus subtype Zaire (Ebo-Z) induces acute haemorrhagic fever and a 60–80% mortality rate in humans. Inflammatory responses were monitored in victims and survivors of Ebo-Z haemorrhagic fever during two recent outbreaks in Gabon. Survivors were characterized by a transient release in plasma of interleukin-1β (IL-1β), IL-6, tumour necrosis factor-α (TNFα), macrophage inflammatory protein-1α (MIP-1α) and MIP-1β early in the disease, followed by circulation of IL-1 receptor antagonist (IL-1RA) and soluble receptors for TNFα (sTNF-R) and IL-6 (sIL-6R) towards the end of the symptomatic phase and after recovery. Fatal infection was associated with moderate levels of TNFα and IL-6, and high levels of IL-10, IL-1RA and sTNF-R, in the days before death, while IL-1β was not detected and MIP-1α and MIP-1β concentrations were similar to those of endemic controls. Simultaneous massive activation of monocytes/macrophages, the main target of Ebo-Z, was suggested in fatal infection by elevated neopterin levels. Thus, presence of IL-1β and of elevated concentrations of IL-6 in plasma during the symptomatic phase can be used as markers of non-fatal infection, while release of IL-10 and of high levels of neopterin and IL-1RA in plasma as soon as a few days after the disease onset is indicative of a fatal outcome. In conclusion, recovery from Ebo-Z infection is associated with early and well-regulated inflammatory responses, which may be crucial in controlling viral replication and inducing specific immunity. In contrast, defective inflammatory responses and massive monocyte/macrophage activation were associated with fatal outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Auphan, N., DiDonato, J. A., Rosette, C., Helmberg, A., & Karin, M. (1995) · Science · doi:10.1126/science.270.5234.286 · Cited by 2,390
Pasparakis, M., Alexopoulou, L., Episkopou, V, & Kollias, G. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.4.1397 · Cited by 1,160
Interleukin-1 receptor antagonist reduces mortality from endotoxin shock
Ohlsson, K., Björk, P., Bergenfeldt, M., Hageman, R., & Thompson, R. C. (1990) · Nature · doi:10.1038/348550a0 · Cited by 853
Van Zee, K. J., Kohno, T., Fischer, E., Rock, C. S., Moldawer, L. L., & Lowry, S. F. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.11.4845 · Cited by 845
Ding, L., Linsley, P. S., Huang, L. Y., Germain, R. N., & Shevach, E. M. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.3.1224 · Cited by 829
Preferential Migration of Activated CD4 + and CD8 + T Cells in Response to MIP-1α and MIP-1β
Taub, D. D., Conlon, K., Lloyd, A. R., Oppenheim, J. J., & Kelvin, D. J. (1993) · Science · doi:10.1126/science.7682337 · Cited by 730
Development of a preventive vaccine for Ebola virus infection in primates
Sullivan, N. J., Sanchez, A., Rollin, P. E., Yang, Z.-Y., & Nabel, G. J. (2000) · Nature · doi:10.1038/35046108 · Cited by 663
Inflammatory Cytokines Provide a Third Signal for Activation of Naive CD4+ and CD8+ T Cells
Curtsinger, J. M., Schmidt, C. S., Mondino, A., Lins, D. C., Kedl, R. M., Jenkins, M. K., & Mescher, M. F. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.6.3256 · Cited by 616
de Waal Malefyt, R., Yssel, H., & de Vries, J. E. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.11.4754 · Cited by 603
Neopterin as a marker for activated cell-mediated immunity: Application in HIV infection
Fuchs, D., Hausen, A., Reibnegger, G., Werner, E. R., Dierich, M. P., & Wachter, H. (1988) · Immunology Today · doi:10.1016/0167-5699(88)91203-0 · Cited by 563
Sanchez, A., Trappier, S. G., Mahy, B. W., Peters, C. J., & Nichol, S. T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3602 · Cited by 552
Baize, S., Leroy, E. M., Georges-Courbot, M.-C., Capron, M., Lansoud-Soukate, J., Debré, P., Fisher-Hoch, S. P., McCormick, J. B., & Georges, A. J. (1999) · Nature Medicine · doi:10.1038/7422 · Cited by 551
Self-citationA Mouse Model for Evaluation of Prophylaxis and Therapy of Ebola Hemorrhagic Fever
Bray, M., Davis, K., Geisbert, T., Schmaljohn, C., & Huggins, J. (1998) · The Journal of Infectious Diseases · doi:10.1086/515386 · Cited by 492
Ebola haemorrhagic fever in Zaire
Otatume, S. (1996) · Journal of African Studies · doi:10.11619/africa1964.1996.49_95 · Cited by 474
Epitopes Involved in Antibody-Mediated Protection from Ebola Virus
Wilson, J. A., Hevey, M., Bakken, R., Guest, S., Bray, M., Schmaljohn, A. L., & Hart, M. K. (2000) · Science · doi:10.1126/science.287.5458.1664 · Cited by 459
Nabel, G. J., Yang, Z., Duckers, H. J., Sullivan, N. J., Sanchez, A., & Nabel, E. G. (2000) · Nature Medicine · doi:10.1038/78645 · Cited by 413
Human asymptomatic Ebola infection and strong inflammatory response
Leroy, E., Baize, S., Volchkov, V., Fisher-Hoch, S., Georges-Courbot, M.-C., Lansoud-Soukate, J., Capron, M., Debré, P., Georges, A., & McCormick, J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02405-3 · Cited by 411
Self-citationKsiazek, T. G., Rollin, P. E., Williams, A. J., Bressler, D. S., Martin, M. L., Swanepoel, R., Burt, F. J., Leman, P. A., Khan, A. S., Rowe, A. K., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/514321 · Cited by 359
Oswald, I. P., Wynn, T. A., Sher, A., & James, S. L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.18.8676 · Cited by 353
Villinger, F., Rollin, P. E., Brar, S. S., Chikkala, N. F., Winter, J., Sundstrom, J. B., Zaki, S. R., Swanepoel, R., Ansari, A. A., & Peters, C. J. (1999) · The Journal of Infectious Diseases · doi:10.1086/514283 · Cited by 307
Apoptosis Induced In Vitro and In Vivo During Infection by Ebola and Marburg Viruses
Geisbert, T. W., Hensley, L. E., Gibb, T. R., Steele, K. E., Jaax, N. K., & Jahrling, P. B. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780021 · Cited by 302
Ebola Hemorrhagic Fever Outbreaks in Gabon, 1994–1997: Epidemiologic and Health Control Issues
Georges, A., Leroy, E. M., Renaut, A. A., Benissan, C. T., Nabias, R. J., Ngoc, M. T., Obiang, P. I., Lepage, J. P. M., Bertherat, E. J., Bénoni, D. D., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/514290 · Cited by 298
Self-citationPeters, M., Jacobs, S., Ehlers, M., Vollmer, P., Müllberg, J., Wolf, E., Brem, G., Meyer zum Büschenfelde, K. H., & Rose-John, S. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.4.1399 · Cited by 276
Filovirus-induced endothelial leakage triggered by infected monocytes/macrophages
Feldmann, H., Bugany, H., Mahner, F., Klenk, H. D., Drenckhahn, D., & Schnittler, H. J. (1996) · Journal of Virology · doi:10.1128/jvi.70.4.2208-2214.1996 · Cited by 256
The role of the Type I interferon response in the resistance of mice to filovirus infection
Bray, M. (2001) · Journal of General Virology · doi:10.1099/0022-1317-82-6-1365 · Cited by 228
[The epidemic of Ebola haemorrhagic fever in Sudan and Zaire, 1976: introductory note].
Brès, P. (1978) · Europe PMC (PubMed Central) · Cited by 225
van Deuren, M., van der Ven-Jongekrijg, J., Bartelink, A. K. M., van Dalen, R., Sauerwein, R. W., & van der Meer, J. W. M. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/172.2.433 · Cited by 225
A case for cytokines as effector molecules in the resolution of virus infection
Ramsay, A. J., Ruby, J., & Ramshaw, I. A. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90277-r · Cited by 212
Immunization for Ebola virus infection
Xu, L., Sanchez, A., Yang, Z.-Y., Zaki, S. R., Nabel, E. G., Nichol, S. T., & Nabel, G. J. (1998) · Nature Medicine · doi:10.1038/nm0198-037 · Cited by 196
Gupta, M., Mahanty, S., Ahmed, R., & Rollin, P. E. (2001) · Virology · doi:10.1006/viro.2001.0836 · Cited by 192
Evans, T. J., Moyes, D., Carpenter, A., Martin, R., Loetscher, H., Lesslauer, W., & Cohen, J. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.6.2173 · Cited by 174
Pathologic Features of Filovirus Infections in Humans
Zaki, S. R., & Goldsmith, C. S. (1999) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-59949-1_7 · Cited by 166
Protection from Ebola Virus Mediated by Cytotoxic T Lymphocytes Specific for the Viral Nucleoprotein
Wilson, J. A., & Hart, M. K. (2001) · Journal of Virology · doi:10.1128/jvi.75.6.2660-2664.2001 · Cited by 163
Gupta, M., Mahanty, S., Bray, M., Ahmed, R., & Rollin, P. E. (2001) · Journal of Virology · doi:10.1128/jvi.75.10.4649-4654.2001 · Cited by 147
Isolation and Phylogenetic Characterization of Ebola Viruses Causing Different Outbreaks in Gabon
Georges-Courbot, M. C., Sanchez, A., Lu, C. Y., Baize, S., Leroy, E. M., Lansoud-Soukate, J., Tévi‐Bénissan, C., Georges, A. J., Trappier, S. G., Zaki, S. R., et al. (1997) · Emerging infectious diseases · doi:10.3201/eid0301.970107 · Cited by 133
Self-citationSchnittler, H., Mahner, F., Drenckhahn, D., Klenk, H., & Feldmann, H. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116329 · Cited by 123
Ebola virus infection in guinea pigs: presumable role of granulomatous inflammation in pathogenesis
Ryabchikova, E. I., Колесникова, Л. И., Smolina, M. I., Tkachev, V., Pereboeva, L., Баранова, С. Г., Grazhdantseva, A. A., & Rassadkin, Y. N. (1996) · Archives of Virology · doi:10.1007/bf01718165 · Cited by 104
Molecular Pathogenesis of Filovirus Infections: Role of Macrophages and Endothelial Cells
Schnittler, H., & Feldmann, H. (1999) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-59949-1_10 · Cited by 96
Leroy, E. M., Baize, S., Mavoungou, E., & Apetrei, C. (2002) · Journal of General Virology · doi:10.1099/0022-1317-83-1-67 · Cited by 49
Self-citationProcessing of the Ebola Virus Glycoprotein
Volchkov, V. E. (1999) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-59949-1_3 · Cited by 44
Immune Response to Filovirus Infections
Ignatyev, G. M. (1999) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-59949-1_11 · Cited by 34
Cited by
Feldmann, H., & Geisbert, T. W. (2011) · The Lancet · doi:10.1016/s0140-6736(10)60667-8 · Cited by 1,374
Al-Bari, M. A. A. (2017) · Pharmacology Research & Perspectives · doi:10.1002/prp2.293 · Cited by 382
Wauquier, N., Becquart, P., Padilla, C., Baize, S., & Leroy, E. M. (2010) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0000837 · Cited by 377
Self-citationCutting Edge: Impairment of Dendritic Cells and Adaptive Immunity by Ebola and Lassa Viruses
Mahanty, S., Hutchinson, K., Agarwal, S., Mcrae, M., Rollin, P. E., & Pulendran, B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.6.2797 · Cited by 354
Basic Clinical and Laboratory Features of Filoviral Hemorrhagic Fever
Kortepeter, M. G., Bausch, D. G., & Bray, M. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir299 · Cited by 328
Metadata
- Authors
- BAIZE, S., LEROY, E. M., GEORGES, A. J., GEORGES-COURBOT, M.-C., CAPRON, M., BEDJABAGA, I., LANSOUD-SOUKATE, J., & MAVOUNGOU, E.
- Venue
- Clinical and Experimental Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-04
- Volume
- 128
- Issue
- 1
- Pages
- 163-168
- ISSN
- 0009-9104 (ISSN-L)
- 1365-2249
- OpenAlex
- W2038501005
- Cited by
- 370
- References
- 42
- FWCI
- 6.53
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.